Experiments are the lifeblood of R&D, but reagent failure drains important resources and impedes the advancement of quality candidates

36.1% of experimental failure is due to reagents not working as intended**
$17.6 billion is lost by life science companies on this problem each year*†
Pipelines stall and patients wait as drugs get delayed

* Freedman, L., Cockburn, I. and Simcoe, T. (2015). The Economics of Reproducibility in Preclinical Research. PLOS Biology, 13(6), p.e1002165.

† Freedman et al. report figures for the US only. We have extrapolated their data to reflect the fact that the US accounts for 58% of global pharmaceutical R&D.
See https://www.abpi.org.uk/facts-and-figures/science-and-innovation/worldwide-pharmaceutical-company-rd-expenditure-by-country/.

BenchSci returns time to scientists and reduces unnecessary spend

We exponentially increase the speed and quality of life-saving research by empowering scientists with the world’s most advanced biomedical artificial intelligence to run more successful experiments.

Using machine learning, BenchSci puts the world’s biomedical knowledge at scientists' fingertips

1 - Curate
2 - Decode
3 - Present

Curate the world's largest collection of data from life science experiments and reagent catalogs

InfoPanel01_550H
Vertical_Infographic01

Decode and organize the information with reagent-specific machine learning models

InfoPanel02_550H
Vertical_Infographic02

Provide rapid insights in a clear, easy-to-use interface with turnkey deployment across an enterprise

InfoPanel03_550H
Vertical_Infographic03

The interface

BenchSci is the world leader in AI-Assisted Reagent Selection and experiment design

15 of the top 20 pharmaceutical companies in the world trust BenchSci, and it is used by over 31,000 scientists at 3,600 institutions worldwide

$0m

Companies using BenchSci save up to $6 million per year in hard costs alone**

** Based on proprietary customer spend analysis. Depends on a number of factors, including a company’s total annual reagent spend and its waste ratio.
If we had BenchSci we would have saved 3 months on our project
— Scientist at top 15 pharma company

Researchers using BenchSci move faster, with less time searching for and validating reagents

In partnership with the world's leading scientific publishers

spring nature 3
pnas 3
karger 3
wolters 3
wiley 3
aspet 3
asbmb 3
faseb 3
jama 1
83%

Over 80% of scientists say that BenchSci accelerates their work^

^ On average from surveys conducted on hundreds of industry scientists across various therapeutic areas and geographies.
gradient-ventures

Proudly funded by F-Prime and Gradient Ventures, Google’s AI fund

Improve both the speed and quality of your R&D with BenchSci

Flask_Plexus 1 Industry
Get BenchSci’s AI-Assisted Reagent Selection for your enterprise
Learn More
Graduation_Plexus 1 Academics
Get access to BenchSci’s AI-Assisted Antibody Selection free
Sign Up